Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe maintenance dose of tirzepatide is the strength you settle on for the long term, once the gradual titration phase is complete. For most people that lands somewhere between 5 mg and 15 mg weekly, depending on how their body responds and what their prescriber judges to be both effective and well-tolerated. Tirzepatide is a prescription-only medicine, and the dose you end up on is a clinical decision, not a personal preference — your prescriber reviews your progress at each stage before any change is made. If you're exploring how this works in practice, the sections below walk through exactly what the titration ladder looks like, what 'maintenance' actually means in clinical terms, and what to expect once you're there.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide comes in six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Treatment always begins at 2.5 mg. That first pen's job is adjustment, giving your digestive system four weeks to get used to the medicine before the dose climbs. The 2.5 mg level isn't where any meaningful weight change is expected; it exists to reduce the chance of nausea and other gastrointestinal side effects that are more likely when you start too high.
After roughly four weeks, a prescriber would typically consider moving to 5 mg, then 7.5 mg, and so on, with about a month at each rung. This isn't a fixed conveyor belt. If someone is still experiencing significant side effects at a given level, their prescriber might recommend staying there longer rather than pushing upward. The NHS tirzepatide patient information page outlines the general titration approach; the Mounjaro SmPC on the eMC gives the exact prescribing detail. You can read more about how this plays out dose by dose on our Mounjaro treatment page.
The full climb to 15 mg, if that's where someone ends up, takes at least five months of careful stepping. Patience isn't just advised, it's built into the licensed schedule.
In clinical terms, 'maintenance' simply means the dose you continue on once you and your prescriber have established that it's working and manageable. It isn't automatically 15 mg. For some people, 5 mg or 7.5 mg achieves sufficient appetite regulation with minimal side effects, and staying there is entirely appropriate. For others, continuing to titrate toward the higher end produces better results without intolerable symptoms.
The NICE appraisal of tirzepatide (TA1026, published December 2024) notes that if someone hasn't lost at least 5% of their body weight after six months at the highest tolerated dose, continuing treatment should be reviewed. That 'highest tolerated dose' framing matters: NICE and the prescribing guidance both recognise that not everyone will reach 15 mg, nor should they push for it at the cost of wellbeing.
A practical habit worth building: once a month, before you collect your next pen, check your weight and note how you're feeling at the current dose. That ninety-second check gives your prescriber real information to work with at review. Our team covers what the maintenance dose for Mounjaro actually means in practice in more detail on the maintenance dosing overview.
Most people find that the gastrointestinal side effects (nausea, loose stools, indigestion) are most noticeable after each dose increase, then settle over the following one to two weeks. Once you've been stable on a dose for a month or more, your body has generally adapted to that level. That's one of the reasons the titration schedule is slow by design.
Appetite regulation tends to feel more consistent on a steady maintenance dose than during the climb. Food feels less urgent, portion sizes naturally shrink, and energy intake falls without the kind of deliberate restriction that's hard to sustain. This doesn't mean the work is done. Tirzepatide is licensed alongside a reduced-calorie diet and increased physical activity, and that lifestyle context remains important throughout treatment, not just at the start.
If you're thinking about what maintenance looks like financially, there's useful context on the Mounjaro cost page, including why the price structure in the UK changed significantly in late 2025. Practically speaking, higher doses cost more per pen, which is another reason some people and their prescribers weigh whether stepping up further is the right call given the additional benefit being achieved.
Pregnancy, breastfeeding, and trying to conceive are all situations where tirzepatide is not recommended, and the medicine is not licensed for under-18s. If your circumstances change, that conversation with your prescriber should happen before your next dose, not after.
There's no algorithm that spits out the correct dose based on your starting BMI. A prescriber looks at several things together: how much weight change has occurred at each level, what side effects you've reported, any other medicines you're taking (oral contraceptives, for instance, may need a non-oral backup during the first four weeks of treatment and after each dose increase, because tirzepatide can reduce pill absorption), and your overall clinical picture. If you want a closer look at how those decisions are made, our pages on Mounjaro maintenance dosing and maintenance dosing for tirzepatide walk through the key considerations in detail, and you can find further guidance on how the maintenance dose of tirzepatide is determined for different people depending on their response and tolerability.
At nume (sorry, at our pharmacy) every repeat prescription is personally reviewed by a GPhC-registered Independent Prescriber before it goes out. That review isn't a formality. It's where dose decisions get made. If a dose increase is clinically appropriate and you've provided the evidence your prescriber needs, it moves forward. If not, a conversation happens first. There are no automatic escalations.
If you have questions that aren't covered here, the FAQs section addresses many common concerns, and our team is available seven days a week for aftercare support via our contact page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.